Trough colistin plasma level is an independent risk factor for nephrotoxicity: a prospective observational cohort study-Reference-Cited by-同舟云学术

Trough colistin plasma level is an independent risk factor for nephrotoxicity: a prospective observational cohort study

Published:2013-08-19 Issue:1 Volume:13 Page:
ISSN:1471-2334
Container-title:BMC Infectious Diseases
language:en
Short-container-title:BMC Infect Dis

Author:

Sorlí Luisa,Luque Sonia,Grau Santiago,Berenguer Núria,Segura Concepción,Montero María Milagro,Álvarez-Lerma Francisco,Knobel Hernando,Benito Natividad,Horcajada Juan P

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases

Link

http://link.springer.com/article/10.1186/1471-2334-13-380/fulltext.html

Reference31 articles.

1. Falagas ME, Rafailidis PI, Kasiakou SK, Hatzopoulou P, Michalopoulos A: Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin-meropenem combination therapy for multidrug-resistant gram-negative bacterial infections. Clin Microbiol Infect. 2006, 12: 1227-1230. 10.1111/j.1469-0691.2006.01559.x.

2. Montero M, Horcajada JP, Sorli L, Alvarez-Lerma F, Grau S, Riu M, et al: Effectiveness and safety of colistin for the treatment of multidrug-resistant pseudomonas aeruginosa infections. Infection. 2009, 37: 461-465. 10.1007/s15010-009-8342-x.

3. Ouderkirk JP, Nord JA, Turett GS, Kislak JW: Polymyxin B nephrotoxicity and efficacy against nosocomial infections caused by multiresistant gram-negative bacteria. Antimicrob Agents Chemother. 2003, 47: 2659-2662. 10.1128/AAC.47.8.2659-2662.2003.

4. Yahav D, Farbman L, Leibovici L, Paul M: Colistin: New lessons on an old antibiotic. Clin Microbiol Infect. 2012, 18: 18-29. 10.1111/j.1469-0691.2011.03734.x.

5. Garnacho-Montero J, Amaya-Villar R: Multiresistant acinetobacter baumannii infections: epidemiology and management. Curr Opin Infect Dis. 2010, 23: 332-339. 10.1097/QCO.0b013e32833ae38b.

Cited by 187 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of colistin plus beta-lactams for bone and joint infection caused by fluoroquinolone-resistant gram-negative bacilli: a prospective multicenter study;Infection;2024-09-09

2. New Predictive Equation for the Estimation of Plasma Concentrations of Formed Colistin in Patients Treated With Colistimethate Sodium for Multidrug-Resistant Gram-Negative Bacterial Infections;Therapeutic Drug Monitoring;2024-07-09

3. Machine learning algorithms to predict colistin-induced nephrotoxicity from electronic health records in patients with multidrug-resistant Gram-negative infection;International Journal of Antimicrobial Agents;2024-07

4. Implementation of Modern Therapeutic Drug Monitoring and Lipidomics Approaches in Clinical Practice: A Case Study with Colistin Treatment;Pharmaceuticals;2024-06-07

5. Genetic predisposition and high exposure to colistin in the early treatment period as independent risk factors for colistin‐induced nephrotoxicity;Clinical and Translational Science;2024-03